US Stock MarketDetailed Quotes

FULC Fulcrum Therapeutics

Watchlist

7.910
+0.560+7.62%

Close May 14 16:00 ET

491.64MMarket Cap-4913P/E (TTM)

Fulcrum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

-55.77%2.81M

27.15%871K

-35.84%759K

-53.24%880K

-88.62%295K

-66.90%6.34M

-86.46%685K

-76.03%1.18M

-57.04%1.88M

Operating revenue

--0

-55.77%2.81M

27.15%871K

-35.84%759K

-53.24%880K

-88.62%295K

-66.90%6.34M

-86.46%685K

-76.03%1.18M

-57.04%1.88M

Cost of revenue

Gross profit

Operating expense

5.66%29.83M

-4.23%113.47M

0.58%28.86M

12.47%28.2M

-22.00%28.17M

-1.24%28.24M

18.22%118.48M

0.28%28.7M

-2.46%25.07M

50.09%36.12M

Selling and administrative expenses

-12.66%10.06M

-0.06%41.67M

-2.63%9.86M

2.62%9.96M

-6.98%10.32M

7.07%11.52M

36.63%41.69M

4.38%10.13M

12.51%9.71M

66.01%11.1M

-General and administrative expense

-12.66%10.06M

-0.06%41.67M

-2.63%9.86M

2.62%9.96M

-6.98%10.32M

7.07%11.52M

36.63%41.69M

4.38%10.13M

12.51%9.71M

66.01%11.1M

Research and development costs

18.29%19.77M

-6.49%71.8M

2.33%19M

18.69%18.24M

-28.66%17.85M

-6.26%16.72M

10.16%76.78M

-1.83%18.57M

-10.02%15.37M

43.97%25.02M

Operating profit

-6.78%-29.83M

1.31%-110.66M

0.07%-27.99M

-14.86%-27.44M

20.28%-27.29M

-7.47%-27.94M

-38.34%-112.13M

-18.90%-28.01M

-15.02%-23.89M

-73.94%-34.24M

Net non-operating interest income expense

Other net income (expense)

-6.23%2.96M

489.00%13.33M

72.49%3.24M

2,151.97%3.42M

2,026.67%3.51M

4,415.71%3.16M

993.24%2.26M

2,401.33%1.88M

181.48%152K

385.29%165K

Special income (charges)

----

--0

----

---427K

--38K

---465K

----

-Less：Restructuring and merger&acquisition

----

--0

----

--427K

---38K

--465K

----

Other non- operating income (expenses)

-6.23%2.96M

395.50%13.33M

76.06%3.24M

454.78%3.42M

2,026.67%3.51M

4,415.71%3.16M

1,199.52%2.69M

2,350.67%1.84M

1,042.59%617K

385.29%165K

Income before tax

-8.44%-26.87M

11.41%-97.34M

5.28%-24.76M

-1.18%-24.02M

30.19%-23.78M

4.43%-24.78M

-35.90%-109.87M

-11.29%-26.14M

-14.59%-23.74M

-73.40%-34.07M

Income tax

Net income

-8.44%-26.87M

11.41%-97.34M

5.28%-24.76M

-1.18%-24.02M

30.19%-23.78M

4.43%-24.78M

-35.90%-109.87M

-11.29%-26.14M

-14.59%-23.74M

-73.40%-34.07M

Net income continuous Operations

-8.44%-26.87M

11.41%-97.34M

5.28%-24.76M

-1.18%-24.02M

30.19%-23.78M

4.43%-24.78M

-35.90%-109.87M

-11.29%-26.14M

-14.59%-23.74M

-73.40%-34.07M

Minority interest income

Net income attributable to the parent company

-8.44%-26.87M

11.41%-97.34M

5.28%-24.76M

-1.18%-24.02M

30.19%-23.78M

4.43%-24.78M

-35.90%-109.87M

-11.29%-26.14M

-14.59%-23.74M

-73.40%-34.07M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-8.44%-26.87M

11.41%-97.34M

5.28%-24.76M

-1.18%-24.02M

30.19%-23.78M

4.43%-24.78M

-35.90%-109.87M

-11.29%-26.14M

-14.59%-23.74M

-73.40%-34.07M

Basic earnings per share

-4.88%-0.43

34.84%-1.59

20.00%-0.4

23.53%-0.39

54.22%-0.38

35.94%-0.41

-6.55%-2.44

13.79%-0.5

10.53%-0.51

-38.33%-0.83

Diluted earnings per share

-4.88%-0.43

34.84%-1.59

20.00%-0.4

23.53%-0.39

54.22%-0.38

35.94%-0.41

-6.55%-2.44

13.79%-0.5

10.53%-0.51

-38.33%-0.83

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	-55.77%2.81M	27.15%871K	-35.84%759K	-53.24%880K	-88.62%295K	-66.90%6.34M	-86.46%685K	-76.03%1.18M	-57.04%1.88M
Operating revenue	--0	-55.77%2.81M	27.15%871K	-35.84%759K	-53.24%880K	-88.62%295K	-66.90%6.34M	-86.46%685K	-76.03%1.18M	-57.04%1.88M
Cost of revenue
Gross profit
Operating expense	5.66%29.83M	-4.23%113.47M	0.58%28.86M	12.47%28.2M	-22.00%28.17M	-1.24%28.24M	18.22%118.48M	0.28%28.7M	-2.46%25.07M	50.09%36.12M
Selling and administrative expenses	-12.66%10.06M	-0.06%41.67M	-2.63%9.86M	2.62%9.96M	-6.98%10.32M	7.07%11.52M	36.63%41.69M	4.38%10.13M	12.51%9.71M	66.01%11.1M
-General and administrative expense	-12.66%10.06M	-0.06%41.67M	-2.63%9.86M	2.62%9.96M	-6.98%10.32M	7.07%11.52M	36.63%41.69M	4.38%10.13M	12.51%9.71M	66.01%11.1M
Research and development costs	18.29%19.77M	-6.49%71.8M	2.33%19M	18.69%18.24M	-28.66%17.85M	-6.26%16.72M	10.16%76.78M	-1.83%18.57M	-10.02%15.37M	43.97%25.02M
Operating profit	-6.78%-29.83M	1.31%-110.66M	0.07%-27.99M	-14.86%-27.44M	20.28%-27.29M	-7.47%-27.94M	-38.34%-112.13M	-18.90%-28.01M	-15.02%-23.89M	-73.94%-34.24M
Net non-operating interest income expense
Other net income (expense)	-6.23%2.96M	489.00%13.33M	72.49%3.24M	2,151.97%3.42M	2,026.67%3.51M	4,415.71%3.16M	993.24%2.26M	2,401.33%1.88M	181.48%152K	385.29%165K
Special income (charges)	----	--0	--0	--0	----	----	---427K	--38K	---465K	----
-Less：Restructuring and merger&acquisition	----	--0	--0	--0	----	----	--427K	---38K	--465K	----
Other non- operating income (expenses)	-6.23%2.96M	395.50%13.33M	76.06%3.24M	454.78%3.42M	2,026.67%3.51M	4,415.71%3.16M	1,199.52%2.69M	2,350.67%1.84M	1,042.59%617K	385.29%165K
Income before tax	-8.44%-26.87M	11.41%-97.34M	5.28%-24.76M	-1.18%-24.02M	30.19%-23.78M	4.43%-24.78M	-35.90%-109.87M	-11.29%-26.14M	-14.59%-23.74M	-73.40%-34.07M
Income tax
Net income	-8.44%-26.87M	11.41%-97.34M	5.28%-24.76M	-1.18%-24.02M	30.19%-23.78M	4.43%-24.78M	-35.90%-109.87M	-11.29%-26.14M	-14.59%-23.74M	-73.40%-34.07M
Net income continuous Operations	-8.44%-26.87M	11.41%-97.34M	5.28%-24.76M	-1.18%-24.02M	30.19%-23.78M	4.43%-24.78M	-35.90%-109.87M	-11.29%-26.14M	-14.59%-23.74M	-73.40%-34.07M
Minority interest income
Net income attributable to the parent company	-8.44%-26.87M	11.41%-97.34M	5.28%-24.76M	-1.18%-24.02M	30.19%-23.78M	4.43%-24.78M	-35.90%-109.87M	-11.29%-26.14M	-14.59%-23.74M	-73.40%-34.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-8.44%-26.87M	11.41%-97.34M	5.28%-24.76M	-1.18%-24.02M	30.19%-23.78M	4.43%-24.78M	-35.90%-109.87M	-11.29%-26.14M	-14.59%-23.74M	-73.40%-34.07M
Basic earnings per share	-4.88%-0.43	34.84%-1.59	20.00%-0.4	23.53%-0.39	54.22%-0.38	35.94%-0.41	-6.55%-2.44	13.79%-0.5	10.53%-0.51	-38.33%-0.83
Diluted earnings per share	-4.88%-0.43	34.84%-1.59	20.00%-0.4	23.53%-0.39	54.22%-0.38	35.94%-0.41	-6.55%-2.44	13.79%-0.5	10.53%-0.51	-38.33%-0.83
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall